Kim, S. Y., Myung, J. K., Kim, H., Na, I. I., Koh, J. S., Baek, H. J., & Kim, C. H. (2019). Factors that Predict Clinical Benefit of EGFR TKI Therapy in Patients with EGFR Wild-Type Lung Adenocarcinoma. Tuberc Respir Dis (Seoul).
Citación estilo ChicagoKim, Seo Yun, Jae Kyung Myung, Hye-Ryoun Kim, Im Il Na, Jae Soo Koh, Hee Jong Baek, and Cheol Hyeon Kim. "Factors That Predict Clinical Benefit of EGFR TKI Therapy in Patients With EGFR Wild-Type Lung Adenocarcinoma." Tuberc Respir Dis (Seoul) 2019.
Cita MLAKim, Seo Yun, et al. "Factors That Predict Clinical Benefit of EGFR TKI Therapy in Patients With EGFR Wild-Type Lung Adenocarcinoma." Tuberc Respir Dis (Seoul) 2019.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.